Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on the Activation of Factor VIII and Factor V by Thrombin

スポンサーリンク

概要

• 論文の詳細を見る
• 1996-01-01

著者

• Nagase Hideki

  大鵬薬品工業

• Nagase Hideki

  Department Of Pediatrics Nara Medical University

• Saito H

  Department Of Hematology Meitetsu Hospital

• Yoshioka Akira

  天理市立病院 小児科

• Saito H

  Nagoya Central Hospital

• SAITO Hidehiko

  The First Department of Internal Medicine,Nagoya University School of Medicine

• Yagi A

  Faculty Of Pharmacy And Pharmaceutical Sciences Fukuyama University

• Saito Hidehiko

  The First Department Of Internal Medicine Nagoya University School Of Medicine

• SHIMA Midori

  The Department of Pediatrics, Nara Medical University

• YOSHIOKA Akira

  The Department of Pediatrics, Nara Medical University

• Saito H

  Nagoya National Hospital

• Shima M

  Department Of Pediatrics Nara Medical University

• Shima Midori

  The Department Of Pediatrics Nara Medical University

• NAGASE Hideki

  Taiho Pharmaceutical Co., Ltd.

• ENJYOJI Kei-ichi

  Research Institute, National Cardiovascular Center

• KITAZATO Kenji

  Taiho Pharmaceutical Co., Ltd.

• KATO Hisao

  Research Institute, National Cardiovascular Center

• Saito Hidehiko

  Nagoya Central Hospital Nagoya Jpn

• Yagi A

  Faculty Of Agriculture Shizuoka University

• Yagi Akihito

  Department Of Agricultural Chemistry Shizuoka University

• Sakka Makiko

  Graduate School Of Bioresources Mie Univ.

• Kitazato K

  Taiho Pharmaceutical Co. Ltd.

• Yoshioka A

  Department Of Pediatrics Nara Medical University

• Saito H

  Nagoya Univ. School Of Medicine Nagoya Jpn

• Yoshioka Akira

  The Department Of Neurology Kanazawa Medical University

• Nagase Hideki

  Taiho Pharmaceutical Co. Ltd.

• Enjyoji Kei-ichi

  Research Institute National Cardiovascular Center

• Kato Hisao

  Research Institute National Cardiovascular Center

関連論文

• A SIMPLE AND SELECTIVE HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF PARAQUAT AND DIQUAT IN HUMAN URINE
• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
• Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype
• Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
• Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
• Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
• Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
• Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
• Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
• Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
• Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• Recurrent Mutations of Factor XI Gene in Japanese
• Structural Organization and Promoter Activity of the Human Ryudocan Gene
• Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
• Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
• High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
• Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Recombinant Factor VIIa in Japanese Patients With Hemophilia With Inhibitors
• Observed Decline in the Rate of Death Among Japanese Hemophiliacs Infected With HIV-1
• Pharmacolinetics, Prophylactic Effects, and Safety of a New Recombinant FVIII Formulated with Sucrose (BAY 14-2222) in Japanese Patients with Hemophilia A
• Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
• High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
• Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
• Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
• Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
• Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
• Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
• Individual Dose Adjustment of Oral Busulfan Using a Test Dose in Hematopoietic Stem Cell Transplantation
• Molecular Cloning, Genomic Organization, Promoter Activity, and Tissue-Specific Expression of the Mouse Ryudocan Gene^1
• Analysis for heterozygosity of protein S mRNA: application to genetic screening and family studies in hereditary protein S deficiency
• Interferon-α treatment of acute lymphoblastic leukemia relapse after unrelated bone marrow transplantation
• Granulocyte colony-stimulating factor-combined marrow-ablative chemotherapy and autologous blood cell transplantation for the treatment of patients with acute myelogenous leukemia in first remission
• Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
• A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
• Ecthyma gangrenosum combined with multiple perforations of the small intestine associated with Pseudomonas aeruginosa
• Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
• Quality of Life in Adult Patients After Stem Cell Transplantation
• Superior Efficacy of MMCP Regimen Compared with VMCP and MMPP Regimens in the Treatment of Multiple Myeloma
• Posttreatment Nadir M-Protein Level Is a Stronger Discriminator of Survival Following Plateau Attainment Than Is Percent Reduction in M-Protein in Patients With IgG Myeloma
• Molecular remission achieved by interferon therapy in a patient with cytogenetically relapsed chronic myelogenous leukemia after syngeneic bone marrow transplantation
• Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
• Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
• Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
• Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
• Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond
• Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions
• Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia a patients with factor VIII inhibitor
• Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
• Inversions of the Factor VIII Gene in Japanese Patients with Severe Hemophilia A
• Measurement of anti-factor VIII IgG, IgG4 and IgM alloantibodies in previously untreated hemophilia A patients treated with recombinant factor VIII
• Preschool sarcoidosis mimicking juvenile rheumatoid arthritis: The significance of gallium scintigraphy and skin biopsy in the differential diagnosis
• A case of infantile Alexander disease diagnosed by magnetic resonance imaging and genetic analysis
• Highly Conserved Antigenic Structure of the Factor VIII C2 Domain in Some Mammals
• Anti-factor VIII inhibitor alloantibodies recognizing the A2 domain in the human factor VIII heavy chain poorly bind to porcine factor VIII
• A case of West syndrome with atypical massive gray matter heterotopia that is well controlled by ACTH therapy
• Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on the Activation of Factor VIII and Factor V by Thrombin
• Recovery of Normal Hematopoiesis after Severe Bone Marrow Aplasia Induced by Interferon-α in a Patient with Chronic Myelogenous Leukemia
• Durable Remission by Sobuzoxane in an HIV-Seronegative Patient with Human Herpesvirus 8-Negative Primary Effusion Lymphoma
• Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
• Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer
• Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas
• Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
• WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
• WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
• Wilms Tumor Gene Peptide-Based Immunotherapy for Patients with Overt Leulemia from Myelodysplastic Syndrome (MDS) or MDS with Myelofibrosis
• The lck Promoter-Driven Expression of the Wilms Tumor Gene WT1 Blocks Intrathymic Differentiation of T-Lineage Cells
• Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
• Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma
• Novel Synthesized Trimannose Conjugate Induces Endocytosis and Expression of Immunostimulatory Molecules in Monocytic Leukemia Cells
• Genetic Abnormalities of Bernard-Soulier Syndrome
• Retrospective study of inhibitor formation in Japanese hemophiliacs
• 2-O-(β-L-Arabinopyranosyl)-myo-inositol as a Main Constituent of Tea (Camellia sinensis)(Organic Chemistry)
• WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
• A Simple Screening Method for Antioxidants and Isolation of Several Antioxidants Produced by Marine Bacteria from Fish and Shellfish
• Glycosidic Aroma Precursors of 2-Phenylethyl and Benzyl Alcohols from Jasminum sambac Flowers
• trans- and cis-Linalool 3,6-Oxide 6-O-β-D-Xylopyranosyl-β-D-glucopyranosides Isolated as Aroma Precursors from Leaves for Oolong Tea
• (S)-Linalyl, 2-Phenylethyl, and Benzyl Disaccharide Glycosides Isolated as Aroma Precursors from Oolong Tea Leaves
• Preparation of Congou Black Tea from Stale Green Tea
• Overexpression of the Wilms′tumor gene WT1 in head and neck squamous cell carcinoma
• Isolation of An Aroma Precursor of Benzaldehyde from Tea Leaves (Camellia sinensis var. sinensis cv. Yabukita)
• cis- and trans-Linalool 3,7-Oxides and Methyl Salicylate Glycosides and (Z)-3-Hexenyl β-D-Glucopyranoside as Aroma Precursors from Tea Leaves for Oolong Tea
• Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
• Efficient Induction of Pptide - Specific Cytotoxic T Lymphocytes by LPS - Activated Spleen Cells
• ω-Methylsulfinylalkyl Isothiocyanates in Wasabi, Wasabia japonica Matsum(Food & Nutrition)
• Stabilization of Resistive Wall Mode Due to Shear Alfven Resonace in a Cylindrical Plasma with a Uniform Longitudinal Flow
• Photosensitized Oxygenation of Lycopene
• Compositional Change of Pu-erh Tea during Processing
• Isolation and Identificaiton of (-)-Quinic Acid as an Unidentified Major Tea-component
• Identification of New Constituents of Cider Vineger by ^C-NMR Spectroscopic Study(Food & Nutrition)
• Isolation of Flavonoids and Cerebrosides from the Bark of Prunus jamasakura as Repellents against the Blue Mussel, Mytilus edulis(Organic Chemistry)
• Nonylphenols as Promising Antifouling Agents Found by a Simple Bioassay Method Using the Blue Mussel, Mytilus edulis(Organic Chemistry)
• The First Naturally Occurring 3-Octulose, D-Gluco-L-glycero-3-octulose, as the Main Constituent of Laurus nobilis Flush(Organic Chemistry)
• Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma : case reports of Japanese patients
• Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
• Isothiocyanates as an Attaching Repellent against the Blue Mussel Mytilus edulis(Organic Chemistry)
• An Improved Assay Method for Antifouling Substances Using the Blue Mussel, Mytilus edulis(Organic Chemistry)
• An Acylated Kaempferol Glucoside Isolated from Quercus dentata as a Repellent against the Blue Mussel Mytilus edulis(Organic Chemistry)

もっと見る 閉じる

スポンサーリンク